Everest Clinical Research
Everest Clinical Research, headquartered in California, is a prominent player in the clinical research industry, specialising in providing comprehensive clinical trial services. Founded in 2005, the company has established a strong presence across major operational regions, including the United States and Europe. With a focus on Phase I-IV clinical trials, Everest Clinical Research offers unique solutions that streamline the research process, ensuring high-quality data and patient safety. Their commitment to innovation and excellence has positioned them as a trusted partner for pharmaceutical and biotechnology companies. Notable achievements include successful collaborations with leading organisations, enhancing their reputation in the market. Everest Clinical Research continues to set benchmarks in clinical research, driven by a dedication to advancing medical science and improving patient outcomes.
DitchCarbon Score
How does Everest Clinical Research's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Everest Clinical Research's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Everest Clinical Research's reported carbon emissions
Everest Clinical Research, headquartered in Canada, has not publicly disclosed any specific carbon emissions data for the most recent year. However, the company is committed to reducing its carbon footprint and has set near-term reduction targets, although specific numerical goals have not been provided. As of September 2023, Everest Clinical Research is classified as "Committed" to these near-term targets, indicating a proactive approach to addressing climate change. While the company has not committed to a net-zero target, it has established long-term reduction targets, reflecting its intention to align with industry standards in the pharmaceuticals, biotechnology, and life sciences sector. This commitment is crucial as the industry faces increasing pressure to mitigate climate impacts and enhance sustainability practices. Everest Clinical Research's initiatives are part of a broader trend within the sector, where companies are increasingly recognising the importance of transparency and accountability in their environmental impact. As they move forward, the focus will likely remain on developing actionable strategies to achieve their climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Everest Clinical Research is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
